Marshall Wace North America’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $18.6M | Buy |
206,420
+75,859
| +58% | +$6.84M | 0.08% | 243 |
|
|
2021
Q2 | $12.4M | Buy |
+130,561
| New | +$12.4M | 0.05% | 337 |
|
|
2021
Q1 | – | Sell |
-5,160
| Closed | -$715K | – | 1691 |
|
|
2020
Q4 | $715K | Buy |
+5,160
| New | +$715K | ﹤0.01% | 1014 |
|
|
2018
Q4 | – | Sell |
-3,212
| Closed | -$245K | – | 1604 |
|
|
2018
Q3 | $245K | Buy |
+3,212
| New | +$245K | ﹤0.01% | 819 |
|
|
2018
Q1 | – | Sell |
-12,652
| Closed | -$587K | – | 1655 |
|
|
2017
Q4 | $587K | Buy |
+12,652
| New | +$587K | ﹤0.01% | 1112 |
|